TrialTranslational stroke research2025

Tenecteplase Plus Butyphthalide for Stroke Within 4.5-6 Hours of Onset (EXIT-BT): a Phase 2 Study.

Hui-Sheng Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.